Objective Recent studies suggest that hemostatic and endothelial factors play a pivotal role in the development of cerebral small vessel disease (SVD). Although plasma fibrinogen is an essential factor in the coagulation cascade, the relationship among fibrinogen, cognitive function, and SVD has not been clarified in community-based Asian populations. Because fibrinogen levels of Asians have been reported to be lower than these of Caucasians, the impact of fibrinogen on the development of SVD or dementia in Asians may be different from that of Caucasians. Methods We performed a cross-sectional study using MRI to determine the relationships among fibrinogen, cognitive function, and subclinical SVD in community-based Japanese elderly. Results Subjects with raised fibrinogen levels tended to have more lacunes and higher grades of white matter lesions (WMLs). Additionally, an independent association between fibrinogen and WMLs was determined by logistic regression analyses. Subjects with high fibrinogen levels accompanied by high von Willebrand factors or thrombomodulin levels had an increased tendency for the presence of WMLs. The relationship between the mean Mini-Mental State Examination (MMSE) scores and the quartiles of fibrinogen levels was not statistically significant after controlling for age, gender, and WMLs; however, the mean MMSE scores in subjects without WML were related to the tertiles of the fibrinogen levels even after adjusting for conventional risks and high sensitivity C-reactive protein.
Introduction
White matter lesions (WMLs) and lacunes, resulting from cerebral small vessel disease (SVD), are often detected on brain magnetic resonance imaging (MRI) in the elderly. A significant proportion of these lesions are clinically silent.
cognitive function in the elderly with or without SVD is necessary for determining the risk of dementia.
Fibrinogen, one of the major clotting factors, could act as an important determinant in the thrombotic process. Raised levels of plasma fibrinogen may serve as a pivotal factor in the coagulation cascade. Because fibrinogen is a major determinant of plasma viscosity, higher fibrinogen may reduce blood flow, lead to thrombosis, and consequently cause vascular events (4) . Indeed, there is increasing evidence that elevated fibrinogen levels are associated with an increased risk of coronary heart disease and stroke (4, 5) . Moreover, the Rotterdam study indicated that higher plasma fibrinogen is associated with both vascular dementia and Alzheimer's disease (AD) in the general population (6) . It has also been shown that cognitive dysfunction is associated with increased levels of plasma fibrinogen (7, 8) ; however, it remains unclear whether cognitive dysfunction associated with raised levels of fibrinogen is mediated by cerebral SVD. Several studies have been focused on the relationship between hemostatic/endothelial factors and cognitive function in the community-dwelling elderly (7, 8) ; however, these studies lacked evaluation of the cognitive effect of cerebral SVD in the elderly.
Although hemostatic and endothelial factors are implicated in the pathogenesis of SVD, the association among plasma fibrinogen levels, endothelial dysfunction, and silent SVD (3, 9) or the relationship among fibrinogen, cognitive function, and subclinical SVD (10) has seldom been examined in a cohort of community-dwelling elderly. Populationbased studies in Caucasians have indicated that a raised plasma fibrinogen concentration is associated with the risk of stroke or dementia. The concentration of plasma fibrinogen in Japanese has been reported to be lower than that of Caucasians (11) . Therefore, it is possible that the relationship among plasma fibrinogen levels, cognitive function, and cerebral SVD in Asian populations may be different from that in Caucasians. However, a community-based study focused on the relationship among plasma fibrinogen levels, cognitive function, and subclinical SVD has not been conducted in Asian countries, including Japan. Therefore, we performed a cross-sectional study to determine the relationship among plasma fibrinogen levels, cognitive function, and subclinical SVD in community-dwelling Japanese elderly. Secondly, we examined whether possible associations were independent of conventional risk factors and inflammation. Third, we investigated whether the possible relationship between SVD and fibrinogen levels was strengthened in the presence of endothelial dysfunction. Lastly, we examined whether plasma fibrinogen levels are associated with cognitive function in subjects without WML.
Subjects and Methods

Study population
Details of the present study design have been reported previously (12, 13) . The subjects, all Japanese, were from two different communities in Yamagata Prefecture, i.e., Takahata town and Sagae city. Those aged 61 and 72 years in Takahata town were invited to participate, and 223 (72.8%) of the 61-year-old and 217 (62.7%) of the 72-yearold residents participated. In Sagae city, 490 residents aged 70 to 72 years were randomly invited, and a total of 291 (59.4%) residents participated. Of the 731 subjects, 47 did not have all of the pertinent data (i.e., missing clinical profiles or blood samples), and, thus, they were excluded. Furthermore, subjects with cortical infarcts (n=2) and/or a history of cerebrovascular disease (n=12) were also excluded. Three subjects were excluded as neurologically symptomatic after a comprehensive neurological evaluation. Finally, a total of 667 subjects in the local communities were evaluated, and 651 of those who completed the Mini-Mental State Examination (MMSE) were available for evaluating the relationship among cerebral SVD, cognitive function, and plasma fibrinogen levels. The Medical Ethics Committee of the Yamagata University School of Medicine approved this study, and all participants gave informed consent.
Evaluation of cardiovascular risk factors
In this study, hypertension was defined as having a casual blood pressure (BP) 140/90 mmHg or using medication for hypertension. Hyperlipidemia was defined as having total cholesterol (TC) levels 220 mg/dL or triglyceride levels 150 mg/dL or using medication for hyperlipidemia. After fasting, blood samples were obtained, and a 75 g oral glucose tolerance test was given to those subjects who had never undergone anti-diabetic therapy. Furthermore, the diagnosis of diabetes was determined according to the World Health Organization criteria (14) .
Assessments of MRI scans
Axial T1-, T2-weighted, and fluid-attenuated inversion recovery (FLAIR) images were collected from each subject in our study. A single trained physician, who was blind to the clinical information of each subject, evaluated SVD-related lesions on MR images. Lacunar infarct was defined as a hypo-signal intensity area (3 to 15 mm) on T1-weighted images and was also visible as a hyper-signal intensity area on T2-weighted images. WML was defined as at least one focal lesion in the cerebral white matter with corresponding hyperintensity on FLAIR images. The Fazekas scale was used to evaluate WMLs because this scale has been shown to reflect the pathological severity of cerebral SVD in postmortem examinations (15) .
Evaluation of carotid atherosclerosis
All participants underwent ultrasonography of the carotid arteries to obtain maximal intima-media thickness (IMT) measurements as described previously (12, 13, 16) . The difference between the non-infarct group and the total infarct group was tested using a t test or Mann-Whitney U test. Chi-squared tests were used to compare the proportional data. p <0.05 and p <0.01 are indicated by * and **, respectively. The differences among the non-infarct, single-infarct, and multiple-infarct groups were tested using a one-way ANOVA. p <0.05 and p <0.01 are indicated by # and ## , respectively. Abbreviations: y, years; BP, blood pressure; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; IMT, intima-media thickness; vWF, von Willebrand factor; hs-CRP, high sensitivity C-reactive protein.
Measurement of fibrinogen, high-sensitivity Creactive protein, thrombomodulin, and von Willebrand factor activity
Plasma fibrinogen levels were measured by determining the clotting time of diluted citrated plasma in the presence of a large amount of thrombin using a clotting rate assay reagent (Fibri-Prest Automate, Diagnostica Stago, Asnières, France). For evaluating endothelial dysfunction, we measured plasma von Willebrand factor (vWF) activity and serum thrombomodulin (TM). vWF (ristocetin cofactor) activity was measured by turbidometry with agglutination of stabilized platelets using a commercial kit from Dade Behring (BC von Willebrand Reagent, Dade Behring, Marburg, Germany). Detailed procedures for the measurement of highsensitivity C-reactive protein (hs-CRP) and TM were described previously (13, 16) .
All samples with fibrinogen, hs-CRP, TM, and vWF were measured at the Biomedical Laboratory (BML), Tokyo, Japan.
Data analysis
All analyses were performed using the Statistical Package for the Social Sciences (SPSS, ver. 15.0; SPSS Inc., Chicago, IL, USA). A chi-squared test was used to compare the proportional data, and a t test, Mann-Whitney U test, and ANOVA were used to compare between two or more groups. Spearman's rank correlation coefficients were used to measure the correlations between plasma fibrinogen values and other variables. Because Schmidt et al reported that subjects with grades of 2 and 3 on the Fazekas scale had associated with WML progression (17), we differentiated those subjects from others with WMLs of grades 0 or 1. The prevalence of lacunar infarcts and moderate WMLs (grades of 2 and 3 on the Fazekas scale) were compared among four groups: the quartiles of TM, vWF, and fibrinogen levels. To examine whether cognitive function was associated with fibrinogen levels, the MMSE scores of the four groups (i.e., the quartiles) of fibrinogen levels were analyzed. Additionally, to investigate whether fibrinogen was an independent risk factor for SVD, the odds ratio (OR) was calculated for the likelihood of lacunar infarction and moderate WMLs using multivariate logistic regression analysis. The lowest quartile was used as the reference category in the logistic regression analysis. We also divided the subjects into four groups according to above-or below-median fibrinogen levels and above-or below-median vWF/TM levels. Among these four groups, the ORs of SVD-related lesions were calculated using logistic regression analyses. All results were adjusted for age, gender, systolic BP, anti-hypertensive therapy, diabetes, TC/high-density lipoprotein (HDL) cholesterol ratio, smoking, maximal IMT, and hs-CRP in the logistic regression analyses. Probability values were 2-tailed, and values of <0.05 were considered significant.
Results
Clinical variables and SVD-related brain abnormalities of study subjects
The mean value of plasma fibrinogen was 279.7 mg/dL (SD, 68.5) in our series. As shown in Tables 1 and 2 , raised fibrinogen levels were associated with SVD-related lesions. In addition, the age, prevalence of hypertension, systolic and diastolic BP, and TM were higher in subjects with lacunar infarct(s) than in those with no infarct. A comparison among the four grades of WMLs indicated that subjects with high grades of WMLs had a tendency towards increased age, prevalence of hypertension, systolic and diastolic BP, TM, vWF activity, and hs-CRP.
Association between fibrinogen and other variables
The results of the correlation coefficients between fibrinogen and other variables are summarized in Table 3 . Plasma fibrinogen values were correlated with the number of lacunes (r=0.110) and WMLs (r=0.191), whereas they were negatively correlated with MMSE scores (r= -0.093).
Association between MRI findings and quartiles of TM, vWF, and fibrinogen
As shown in Fig. 1 , raised fibrinogen levels were associated with a greater prevalence of lacunar infarct(s) or moderate WMLs. Furthermore, subjects with higher TM or vWF levels tended to have a higher prevalence of moderate WMLs.
Adjusted relationship between SVD-related lesions and fibrinogen
In the logistic regression analysis, the association between fibrinogen and moderate WMLs was statistically significant even after controlling for age, gender, cardiovascular risk factors, maximal IMT, and hs-CRP. In addition, we found an independent association of fibrinogen and WMLs between the lowest and 3rd quartile and the lowest and 4th quartile of fibrinogen levels (Table 4) . However, we did not uncover a statistically significant association between lacunar infarct and fibrinogen levels.
Adjusted relationship among SVD-related lesions, fibrinogen, and endothelial dysfunction
The median values of fibrinogen, TM, and vWF activity were 272 mg/dL, 2.70 FU/mL, and 89.0%, respectively. The results of the logistic regression analysis indicated that subjects with high plasma fibrinogen levels accompanied by high vWF had an additional risk for the presence of moderate WMLs even after controlling for age, gender, conventional risk, maximal IMT, and hs-CRP ( Fig. 2A) . In addition, having high TM levels slightly raised the adjusted OR for the presence of moderate WMLs in subjects with high fibrinogen levels (Fig. 2B) . As with data on subjects with lacunar infarcts, the co-existence of high TM/vWF and high fibrinogen levels was not independently associated with a risk of lacunar infarcts.
Association between MMSE scores and MRI findings/ fibrinogen levels
The relationship between the MMSE scores and SVDrelated lesions was evident in both lacunar infarct(s) and WML groups (Fig. 3A, 3B) . The relationship between the quartiles of plasma fibrinogen levels and the mean MMSE scores was also statistically significant ( Fig. 3C ; ANOVA, p <0.05); however, the association between MMSE scores and quartiles of fibrinogen levels was not significant after controlling for age, gender, and WMLs. We then performed additional analyses for subjects without WML and found that the mean MMSE score was associated with the tertiles of fibrinogen levels even after controlling for age, gender, systolic BP, diabetes, smoking, and hs-CRP (Fig. 3D AN-COVA, p<0.01) . However, we did not uncover an independent association between the mean MMSE scores and the tertiles of fibrinogen levels in the subjects with WMLs (subjects with Fazekas grades 1 to 3 WMLs). 
Discussion
The present study found that plasma fibrinogen levels were independently associated with the prevalence of subclinical WMLs in community-based Japanese elderly. Although an independent association between the presence of lacune(s) and fibrinogen levels did not reach statistical significance, we found an independent association of fibrinogen and multiple lacunes (multiple lacunes versus less than two lacunes) between the lowest and highest fibrinogen levels in logistic regression analysis (data not shown). These results indicate that plasma fibrinogen levels are closely associated with SVD in the brain. It is noteworthy that raised plasma fibrinogen was associated with cerebral SVD and cognitive function in community-based Japanese elderly despite the fact that the mean plasma fibrinogen value was lower than that of Caucasians. Elevated fibrinogen levels may influence cerebral hypoperfusion resulting from plasma hyperviscosity and consequently accelerate the development of WMLs or lacunes.
Over the past decade or more, growing evidence suggests that endothelial dysfunction plays a pivotal role in the development of cerebral SVD (3, 18) . For example, damage of the endothelial cell layer of blood vessels is an important contributor to platelet activation (19) . Once platelet activation begins, glycoproteins (GP) IIb/IIIa, which are membrane integrin receptors, undergo a conformational change and permit the binding of fibrinogen and vWF. Higher levels of both fibrinogen and vWF may lead to the aggregation of platelets at the site of vascular injury. The present study indicated that the TM value and vWF activity were also associated with the prevalence of subclinical WMLs. Furthermore, co-existence of high TM/vWF and high fibrinogen levels was closely and independently associated with subclinical WMLs. These findings suggest that higher fibrinogen levels increase the risk for subclinical WMLs when accompanied by endothelial dysfunction. Endothelial dysfunction may be responsible for the subsequent breakdown of the blood-brain barrier (BBB). Once the breakdown of the endothelial cell layer begins, leakage of plasma components into the vessel wall may occur. Subsequent narrowing of the arteriolar lumen may lead to reduced blood flow and ischemia in the brain (18) . After vascular damage leading to BBB disruption, fibrinogen gains access to brain parenchyma, and fibrin formation occurs. BBB breakdown and subsequent fibrin deposition in the parenchyma have been found in stroke and AD brains (20) . The binding of the fibrinogen dimer to microglial integrin receptors causes the activation of the NFkB pathway and contributes to inflammatory responses (21, 22) . Furthermore, AD transgenic mice with only one functional fibrinogen gene showed reduced BBB impairment (22) . Specifically, inflammation and vascular injury were reduced in the AD mouse brain when the following conditions were present: 1) pharmacologically decreased plasma fibrinogen; 2) modulation by genetic deficiency in fibrinogen; or 3) pharmacological inhibition by plasmin (22) . Raised fibrinogen levels related to the breakdown of the BBB and subsequent fibrin deposition may contribute to cognitive decline in both AD and vascular dementia patients (22, 23) ; however, it is unclear whether raised fibrinogen is a cause or a consequence of endothelial dysfunction in the human brain.
To date, reports on the relationship between fibrinogen and silent SVD in the general population are inconsistent (9, 10, 24, 25) . The Ohasama study, a cross-sectional study in the Japanese general population, indicated that raised fibrinogen levels were associated with silent cerebrovascular lesions (24) . Schmidt and colleagues previously reported a positive association of silent SVD-related lesions and raised fibrinogen levels in the results of the Austrian stroke prevention study; however, they defined silent SVDrelated lesions as grades 2 & 3 WMLs on the Fazekas scale or lacunes or a combination of them (9) . In contrast to the present study, two population-based studies in Western countries showed that fibrinogen levels were not associated with subclinical WMLs (10, 25) . These inconsistencies may be explained as follows. First, our study assessed the relationship between fibrinogen levels and the grade of WMLs using the Fazekas scale, whereas white matter disease severity was rated using the ordinal scales in the Rotterdam Scan Study (25) and the Cardiovascular Health Study (10) . The different rating scale used for classification may be related to the differences in the results obtained from these studies. Secondly, the impact of higher fibrinogen on the development of SVD may be influenced by the presence or severity of conventional risk factors. The prevalence of diabetes mellitus in our series (16.2%) was relatively higher than that in the Rotterdam scan study (7.0%) or the Cardiovascular Health Study (10.1%). Third, the effect of raised fibrinogen in plasma on the development of SVD might differ, to some extent, among ethnic groups. Several potential genetic factors of SVD include polymorphisms that may be associated with the different findings of these studies (26, 27) . Genetic epidemiological studies may be necessary to resolve these issues.
The results of the present study also indicated that plasma fibrinogen levels were associated with cognitive function in community-based Japanese elderly. The insignificant association of fibrinogen levels with cognitive function after controlling for age, gender, and WMLs may be due to interactions with these factors. Therefore, we examined an independent association between fibrinogen levels and MMSE scores stratified based on the presence of WMLs. Thus, we tested the interaction of fibrinogen levels and WMLs with ANCOVA, which showed marginally significant interactions between these factors (p=0.08). In addition, we performed further analyses to determine the association between MMSE scores and fibrinogen levels in subjects without WML (n=200) and found a significant relationship even after controlling for age, gender, systolic BP, diabetes, smoking, and hs-CRP (ANCOVA; p<0.01). Because the interac-tion of plasma fibrinogen and WMLs was marginally significant, a study of a larger sample size is needed in order to clarify whether there is an independent association between the MMSE scores and fibrinogen in subjects with WMLs.
There are some limitations in the present study. First, a methodological limitation is the potential misclassification of brain lesions. We may have systematically under-or overestimated cerebrovascular lesions determined by the visual rating scale. Second, we used only one test to study cognitive function. Several evaluating batteries, more sensitive than the MMSE, should be used for evaluating mild cognitive changes in further studies.
Third, as genetic factors contribute to the variation in plasma fibrinogen values and structure of the fibrin clot, further study is needed to examine the relationship between variations in fibrinogen genes and cerebral SVD in community-dwelling Japanese elderly (25) . Fourth, because of the cross-sectional design, we could not infer a causal relationship between higher fibrinogen levels and the risk of future stroke or dementia for elderly subjects. Extensive prospective studies are needed to evaluate the associations among higher fibrinogen levels, SVD, and future stroke or dementia in community-based elderly.
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